Early Events in the Molecular Pathogenesis of Lung Cancer
Abstract
The majority of cancer-related deaths in the United States and worldwide are attributed to lung cancer. There are more than 90 million smokers in the United States who represent a significant population at elevated risk for lung malignancy. In other epithelial tumors, it has been shown that if neoplastic lesions can be detected and treated at their intraepithelial stage, patient prognosis is significantly improved. Thus, new strategies to detect and treat lung preinvasive lesions are urgently needed in order to decrease the overwhelming public health burden of lung cancer. Limiting these advances is a poor knowledge of the earliest events that underlie lung cancer development and that would constitute markers and targets for early detection and prevention. This review summarizes the state of knowledge of human lung cancer pathogenesis and the molecular pathology of premalignant lung lesions, with a focus on the molecular premalignant field that associates with lung cancer development. Lastly, we highlight new approaches and models to study genome-wide alterations in human lung premalignancy in order to facilitate the discovery of new markers for early detection and prevention of this fatal disease. Cancer Prev Res; 9(7); 518–27. ©2016 AACR.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 30, 2016
- Source ID
- 10.1158/1940-6207.capr-15-0400
Entities
People
- Avrum E. Spira
- Humam Kadara
- Ignacio I. Wistuba
- Paul Scheet
Organizations
- Boston University
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health
- United States Department of Defense
- University of Texas at Austin